Although previous studies have demonstrated an association between interferon-gamma (IFN-γ) promoter genotype and antibody response kinetics in chickens, the protein levels that may mediate such a gene–trait association have not been determined. The objective of this study, therefore, was to determine the correlation of circulating IFN-γ levels with both the IFN-γ promoter polymorphisms and antibody response in order to evaluate the potential role of IFN-γ protein in mediating genetic control of antibody response in chickens. Antibody response after Salmonella enteritidis (SE) vaccination at day 10, antibody response to sheep red blood cells (SRBCs) and killed Brucella abortus after immunizations at 19 wk and 22 wk, and serum IFN-γ protein level were measured in an F2 population derived from inbred lines. A single nucleotide polymorphism in the IFN-γ promoter region was associated with IFN-γ protein expression as measured by an enzyme-linked immunosorbent assay after both primary and secondary immunizations. Higher IFN-γ protein level was correlated with higher antibody level to SE and with increased maximum level and decreased time to reach the maximum secondary antibody response to SRBCs. These results suggest that one of the mechanisms by which promoter polymorphism of IFN-γ affects antibody production in chickens may involve the circulating level of IFN-γ protein.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 46 • No. 4